Pilot Trial of Zoledronic Acid to Prevent Bone Loss in Hematopoietic Cell Transplant Recipients

NCT02451462 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Logistics

Conditions

Hematopoietic Stem Cell Transplant
Bone Marrow Transplant

Interventions

DRUG: Zoledronic acid

Sponsor

Stanford University

Collaborators

[object Object]